Hyperhomocysteinemia and Cardiovascular Risk: Effect of Vitamin Supplementation in Risk Reduction

E-ISSN： 2212-3938|5|1|30-36

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.1, 2010-01, pp. : 30-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular risk reduction targets in diabetes

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk Reduction in the Extreme Elderly

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 43, Iss. 1, 2013-03 ,pp. : 62-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

Investigating cardiovascular risk reduction – the Rosuvastatin GALAXY Programme^™

By Schuster Herbert Fox Jonathan C

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1187-1200

Informa Healthcare

Access to resources Recommend Favorite

Ascorbic acid [vitamin C] and tocopherol [vitamin E] supplementation during pregnancy does not reduce the risk of pre-eclampsia

Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan

By Barrios Vivencio Escobar Carlos

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1549-1558

Informa Healthcare

Access to resources Recommend Favorite